FDA approves AbbVie's Skyrizi for children with psoriatic disease
Go back to FDA approves AbbVie's Skyrizi for children with psoriatic disease| AbbVie (NYSE: ABBV) | Delayed: 248.78 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $248.78 | 52 Week High | $68.12 | |||
| Open | $248.78 | 52 Week Low | $50.71 | |||
| Day High | $248.78 | P/E | 53.97 | |||
| Day Low | $248.78 | EPS | $4.61 | |||
| Volume | 262 | |||||
